We are proud to announce that Omnigen, in cooperation with the Erasmus Medical Centre and Noraybio (Spain), got granted a Eurostar grant. With this financial support, we will research the clinical diagnostics of pancreatic cancer. Our goal is to use personalized genetic screening to help doctors and surgeons with finding the right treatment for their patients and help them treat the patients in a more personalized way.
PRESS RELEASE Utrecht, the Netherlands, Oct. 6, 2022 – The research group of Dr. Patrick Kemmeren of the Princess Máxima Center for pediatric oncology will […]
Omnigen is looking for a PhD candidate for the project “Statistics for Biologists: Leveraging user design for transcriptomics analysis”. Statistics and mathematics underpin the algorithms […]
We are delighted to announce that our new project ‘ISOLATE’ (DIagnoStic tOol Liver cAncer TreatmEnt) with Levels Diagnostics has been granted the MIT R&D collaboration […]
